FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983777147> ?p ?o ?g. }

• W1983777147 endingPage "e30308" @default.
• W1983777147 startingPage "e30308" @default.
• W1983777147 abstract "To understand the development of new psoriasis lesions, we studied a group of moderate-to-severe psoriasis patients who experienced a relapse after ceasing efalizumab (anti-CD11a, Raptiva, Genentech). There were increased CD3(+) T cells, neutrophils, CD11c(+) and CD83(+) myeloid dendritic cells (DCs), but no increase in CD1c(+) resident myeloid DCs. In relapsed lesions, there were many CD11c(+)CD1c(-), inflammatory myeloid DCs identified by TNFSF10/TRAIL, TNF, and iNOS. CD11c(+) cells in relapsed lesions co-expressed CD14 and CD16 in situ. Efalizumab induced an improvement in many psoriasis genes, and during relapse, the majority of these genes reversed back to a lesional state. Gene Set Enrichment Analysis (GSEA) of the transcriptome of relapsed tissue showed that many of the gene sets known to be present in psoriasis were also highly enriched in relapse. Hence, on ceasing efalizumab, T cells and myeloid cells rapidly enter the skin to cause classic psoriasis.Clinicaltrials.gov NCT00115076." @default.
• W1983777147 created "2016-06-24" @default.
• W1983777147 creator A5016203957 @default.
• W1983777147 creator A5020296340 @default.
• W1983777147 creator A5020978454 @default.
• W1983777147 creator A5032904171 @default.
• W1983777147 creator A5038023238 @default.
• W1983777147 creator A5052848661 @default.
• W1983777147 creator A5054327153 @default.
• W1983777147 creator A5061063698 @default.
• W1983777147 creator A5063177957 @default.
• W1983777147 creator A5069569862 @default.
• W1983777147 creator A5069759939 @default.
• W1983777147 creator A5074081568 @default.
• W1983777147 creator A5077076136 @default.
• W1983777147 creator A5080337749 @default.
• W1983777147 date "2012-02-10" @default.
• W1983777147 modified "2023-09-27" @default.
• W1983777147 title "Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs" @default.
• W1983777147 cites W1922326226 @default.
• W1983777147 cites W1969790434 @default.
• W1983777147 cites W1970678723 @default.
• W1983777147 cites W1979929645 @default.
• W1983777147 cites W1990083653 @default.
• W1983777147 cites W1991658642 @default.
• W1983777147 cites W2000851235 @default.
• W1983777147 cites W2004937659 @default.
• W1983777147 cites W2007113430 @default.
• W1983777147 cites W2017583377 @default.
• W1983777147 cites W2018107887 @default.
• W1983777147 cites W2023128342 @default.
• W1983777147 cites W2027978561 @default.
• W1983777147 cites W2062606699 @default.
• W1983777147 cites W2078781814 @default.
• W1983777147 cites W2080090843 @default.
• W1983777147 cites W2082914449 @default.
• W1983777147 cites W2086591847 @default.
• W1983777147 cites W2091548845 @default.
• W1983777147 cites W2092374642 @default.
• W1983777147 cites W2097441266 @default.
• W1983777147 cites W2103018315 @default.
• W1983777147 cites W2112267975 @default.
• W1983777147 cites W2112276896 @default.
• W1983777147 cites W2123679910 @default.
• W1983777147 cites W2126735123 @default.
• W1983777147 cites W2140157156 @default.
• W1983777147 cites W2141016525 @default.
• W1983777147 cites W2156013098 @default.
• W1983777147 cites W2167293386 @default.
• W1983777147 doi "https://doi.org/10.1371/journal.pone.0030308" @default.
• W1983777147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3277585" @default.
• W1983777147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22348003" @default.
• W1983777147 hasPublicationYear "2012" @default.
• W1983777147 type Work @default.
• W1983777147 sameAs 1983777147 @default.
• W1983777147 citedByCount "30" @default.
• W1983777147 countsByYear W19837771472012 @default.
• W1983777147 countsByYear W19837771472013 @default.
• W1983777147 countsByYear W19837771472014 @default.
• W1983777147 countsByYear W19837771472015 @default.
• W1983777147 countsByYear W19837771472016 @default.
• W1983777147 countsByYear W19837771472017 @default.
• W1983777147 countsByYear W19837771472018 @default.
• W1983777147 countsByYear W19837771472019 @default.
• W1983777147 countsByYear W19837771472020 @default.
• W1983777147 countsByYear W19837771472021 @default.
• W1983777147 countsByYear W19837771472022 @default.
• W1983777147 countsByYear W19837771472023 @default.
• W1983777147 crossrefType "journal-article" @default.
• W1983777147 hasAuthorship W1983777147A5016203957 @default.
• W1983777147 hasAuthorship W1983777147A5020296340 @default.
• W1983777147 hasAuthorship W1983777147A5020978454 @default.
• W1983777147 hasAuthorship W1983777147A5032904171 @default.
• W1983777147 hasAuthorship W1983777147A5038023238 @default.
• W1983777147 hasAuthorship W1983777147A5052848661 @default.
• W1983777147 hasAuthorship W1983777147A5054327153 @default.
• W1983777147 hasAuthorship W1983777147A5061063698 @default.
• W1983777147 hasAuthorship W1983777147A5063177957 @default.
• W1983777147 hasAuthorship W1983777147A5069569862 @default.
• W1983777147 hasAuthorship W1983777147A5069759939 @default.
• W1983777147 hasAuthorship W1983777147A5074081568 @default.
• W1983777147 hasAuthorship W1983777147A5077076136 @default.
• W1983777147 hasAuthorship W1983777147A5080337749 @default.
• W1983777147 hasBestOaLocation W19837771471 @default.
• W1983777147 hasConcept C104317684 @default.
• W1983777147 hasConcept C127716648 @default.
• W1983777147 hasConcept C167672396 @default.
• W1983777147 hasConcept C171779818 @default.
• W1983777147 hasConcept C203014093 @default.
• W1983777147 hasConcept C2778513237 @default.
• W1983777147 hasConcept C2779282312 @default.
• W1983777147 hasConcept C2779919695 @default.
• W1983777147 hasConcept C2780564577 @default.
• W1983777147 hasConcept C2780969348 @default.
• W1983777147 hasConcept C3020604521 @default.
• W1983777147 hasConcept C502942594 @default.
• W1983777147 hasConcept C53122370 @default.
• W1983777147 hasConcept C55493867 @default.

• next